Transdermal delivery enhanced by magainin pore-forming peptide
Transdermal delivery enhanced by magainin pore-forming peptide
复制标题
DOI:
10.1016/j.jconrel.2007.05.031
复制
发表时间:
2007-10-08
影响因子:
10.8
通讯作者:
Prausnitz, Mark R.
中科院分区:
文献类型:
--
作者:
Kim, Yeu-Chun;Ludovice, Peter J.;Prausnitz, Mark R.
In this study we tested the hypothesis that magainin, a peptide known to form pores in bacterial cell membranes, can increase skin penneability by disrupting stratum corneum lipid structure. We further hypothesized that magainin's enhancement requires co-administration with a surfactant chemical enhancer to increase magainin penetration into the skin. In support of these hypotheses, exposure to a known surfactant chemical enhancer, N-lauroyl sarcosine (NLS), in 50% ethanol solution increased in vitro skin permeability to fluorescein 15 fold and the combination of magainin and NLS-ethanol synergistically increased skin permeability 47 fold. In contrast, skin penneability was unaffected by exposure to magainin without co-enhancement by NLS-ethanol. Furthermore, confocal microscopy showed that magainin in the presence of NLS-ethanol penetrated deeply and extensively into stratum corneum, whereas magainin alone penetrated poorly into the skin. Additional analysis by Fourier-transform infrared spectroscopy, X-ray diffraction, and differential scanning calorimetry showed that NLS-ethanol disrupted stratum corneum lipid structure and that the combination of magainin and NLS-ethanol disrupted stratum corneum lipids even further. Altogether, these data suggest that NLS-ethanol increased magainin penetration into stratum corneum, which further increased stratum corneum lipid disruption and skin permeability. We believe this is the first study to demonstrate the use of a pore-forming peptide to increase skin permeability. This study also presents the novel concept of using a first chemical enhancer to increase penetration of a second chemical enhancer into the skin to synergistically increase skin permeability to a model drug. (C) 2007 Elsevier B.V. All rights reserved.